Schonfeld Strategic Advisors LLC Agios Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $12.5 Billion
- Q2 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 46,346 shares of AGIO stock, worth $1.64 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,346
Previous 23,600
96.38%
Holding current value
$1.64 Million
Previous $691,000
123.01%
% of portfolio
0.01%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AGIO
# of Institutions
235Shares Held
61.8MCall Options Held
297KPut Options Held
235K-
Farallon Capital Management LLC San Francisco, CA5.77MShares$204 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$172 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$127 Million2.72% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.33MShares$82.3 Million0.65% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.94B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...